Beijing Nuokangda Pharmaceutical Technology Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Beijing Nuokangda Pharmaceutical Technology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Phase I Clinical Study for Evaluation of Pharmacokinetic, Safety, Tolerance of Norcantharidin Lipid Microsphere for Injection in Patients With Solid Tumor (NCT04673396) | Beijing Nuokangda Pharmaceutical Technology Co., Ltd. | 2020-09-22 |
Track Beijing Nuokangda Pharmaceutical Technology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.